Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma. 2018

Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
Medical Center for Digestive Diseases, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China.

Cholangiocarcinoma (CCA) is the as the most frequently observed biliary tract malignancy, which has low survival rate in addition to constrained treatment options; nevertheless, the fundamental molecular phenomenon underlying malignant progression of CCA is quite ambiguous. Recently long non-coding RNAs (lncRNAs) have been found to have significant regulatory functions in several human cancers. Herein, we have figured out that lncRNA SNHG1, with substantially enhanced expression in CCA, is capable of acting as the oncogenic molecule of CCA. As revealed by our data, SNHG1 knockdown extensively inhibited CCA cell migration as well as proliferation in vitro and in vivo. In addition, in accordance with the findings of the RNA-Seq analysis, SNHG1 knockdown exhibited a significant impact on the target genes that were linked to cell migration and regulation of cell proliferation, in addition to the apoptotic phenomenon. In a mechanistic manner, we also showed that SNHG1 bound to the histone methyltransferase enhancer of the zeste homolog 2 (EZH2, which is regarded as the catalytic subunit of the polycomb repressive complex 2 (PRC2), which is an extremely conserved protein complex regulating gene expression with the help of methylating lysine 27 on histone H3), specifying the histone alteration pattern on the target genes, including CDKN1A, and, as a result, altered the CCA cell biology. These data verified a major function of the epigenetic regulation of SNHG1 in CCA oncogenesis, in addition to its likely function as a target for CCA interruption.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001650 Bile Duct Neoplasms Tumors or cancer of the BILE DUCTS. Bile Duct Cancer,Cancer of Bile Duct,Cancer of the Bile Duct,Neoplasms, Bile Duct,Bile Duct Cancers,Bile Duct Neoplasm,Cancer, Bile Duct,Cancers, Bile Duct,Neoplasm, Bile Duct
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics

Related Publications

Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
December 2016, Oncotarget,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
February 2021, Molecular medicine (Cambridge, Mass.),
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
October 2020, Stem cell research & therapy,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
November 2011, BioEssays : news and reviews in molecular, cellular and developmental biology,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
September 2015, Molecular cancer,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
October 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
January 2020, Northern clinics of Istanbul,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
July 2017, Cancer biomarkers : section A of Disease markers,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
December 2004, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Yang Yu, and Mingjiong Zhang, and Ni Wang, and Quanpeng Li, and Jian Yang, and Shuai Yan, and Xuezhi He, and Guozhong Ji, and Lin Miao
April 2011, Oncogene,
Copied contents to your clipboard!